Labiana Health S.A. (LAB)
BME
Closed
Oct 7, 2026
Day's Range
5.6052 wk Range
4.00Overview - LAB - Labiana Health S.A.
Key Statistics
Valuation
Enterprise Value
72.67M
P/E (Trailing)
‪16.94‬
P/E (Forward)
‪6.27‬
PEG Ratio
‪6.27‬
Price / Sales (TTM)
‪0.67‬
Price / Book
‪7.49‬
EV / EBITDA
‪7.52‬
Profitability
Gross Margin
‪147.79%‬
Profit Margin
‪3.36%‬
Operating Margin
‪5.63%‬
Return on Assets
‪8.28%‬
Return on Equity
‪69.73%‬
Ownership
Shares Outstanding
7.16M
Held by Insiders
‪63.07%‬
Held by Institutions
‪9.69%‬
Price stats
Beta
‪0.15‬
50-Day Avg
‪6.31‬
200-Day Avg
‪5.73‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - LAB - Labiana Health S.A.
Peers - LAB - Labiana Health S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BME.
- LABBMELabiana Health S.A.51.78MMarket Cap+33.44%52-week change16.94P/E (Trailing)‪3.36%‬Profit Margin
- ROVIBMELaboratorios Farmacéuticos Rovi SA3.02BMarket Cap+4.23%52-week change16.34P/E (Trailing)‪23.95%‬Profit Margin
- ALMBMEAlmirall, S.A.2.28BMarket Cap-6.86%52-week change37.29P/E (Trailing)‪5.11%‬Profit Margin
- FAEBMEFaes Farma, S.A.1.43BMarket Cap+4.99%52-week change16.80P/E (Trailing)‪11.83%‬Profit Margin
- RJFBMELaboratorio Reig Jofre SA214.20MMarket Cap-7.66%52-week change32.63P/E (Trailing)‪2.05%‬Profit Margin
- PARBMEParlem Telecom Company de Telecomunicacions, S.A.38.22MMarket Cap-265.91%52-week change-3.77P/E (Trailing)‪-8.98%‬Profit Margin
Profile Summary - LAB - Labiana Health S.A.
About
Labiana Health S.A. is a Spain-based pharmaceutical holding company specializing in the development, manufacturing, and marketing of medicines for both animal and human health. It offers a diverse portfolio including anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
